Want to see AU:REG full AI Analyst Report?
Top Page
Regis Healthcare Ltd.
(Sydney:REG)
Select Model
Select Model
Rating:53Neutral
Price Target:
AU$6.00
▼(-1.96% Downside)
Action:Reiterated
Date:08/26/26
The score is anchored by improving financial performance—especially strong cash generation and a multi-year recovery in revenue and profitability—but is constrained by negative equity and thin/variable margins. Technicals are also a headwind with the stock trading below key moving averages, and valuation is only middling due to a relatively high P/E despite a moderate dividend yield.
Positive Factors
Strong Revenue Growth
Sustained double-digit revenue expansion indicates improving operating scale across residential aged care, retirement living and home care. Continued growth can support stronger earnings and help absorb the sector’s substantial labour and compliance costs.
Negative Factors
Negative Shareholders' Equity
Negative equity signals a thin capital cushion and limits financial flexibility even with low debt. It can constrain the company’s ability to absorb operational setbacks or fund expansion internally, making balance-sheet repair an important longer-term priority.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong Revenue Growth
Sustained double-digit revenue expansion indicates improving operating scale across residential aged care, retirement living and home care. Continued growth can support stronger earnings and help absorb the sector’s substantial labour and compliance costs.
Read all positive factors
Regis Healthcare Ltd. (REG) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$1.84B
Dividend Yield2.77%
Average Volume (3M)1.72M
Price to Earnings (P/E)33.5
Beta (1Y)0.87
Revenue Growth16.55%
EPS Growth13.42%
CountryAU
Employees13,000
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)0.18
Shares Outstanding302,361,500
10 Day Avg. Volume1,078,239
30 Day Avg. Volume1,722,836
Financial Highlights & Ratios
PEG Ratio2.88
Price to Book (P/B)-161.60
Price to Sales (P/S)1.46
P/FCF Ratio10.09
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$7.49Price Target Upside22.41% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6
EPS Forecast (FY)0.22
Revenue Forecast (FY)AU$1.48B
Regis Healthcare Ltd. Business Overview & Revenue Model
Company Description
Regis Healthcare Limited is a leading Australian provider specializing in comprehensive care services for the elderly. The company operates a network of residential aged care facilities and delivers a broad spectrum of in-home support. These home-...
How the Company Makes Money
Regis Healthcare makes money primarily by delivering aged care services across three main channels: (1) Residential aged care: The company earns revenue from operating aged care homes, which typically includes a combination of Australian Governmen...
Regis Healthcare Ltd. Financial Statement Overview
Summary
Income Statement
62
Positive
Balance Sheet
34
Negative
Cash Flow
74
Positive
| Breakdown | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.34B | 1.15B | 1.01B | 771.48M | 717.89M |
| Gross Profit | 152.61M | 141.46M | 47.17M | -3.78M | 5.18M |
| EBITDA | 107.13M | 240.44M | 191.45M | 96.81M | 55.86M |
| Net Income | 55.69M | 48.95M | -21.41M | -28.45M | -38.80M |
Balance Sheet | |||||
| Total Assets | 2.60B | 2.11B | 1.81B | 1.71B | 1.76B |
| Cash, Cash Equivalents and Short-Term Investments | 173.77M | 192.47M | 64.91M | 61.32M | 4.15M |
| Total Debt | 3.99M | 5.11M | 3.84M | 71.07M | 113.32M |
| Total Liabilities | 2.61B | 2.12B | 1.84B | 1.67B | 1.68B |
| Stockholders Equity | -12.13M | -16.72M | -22.89M | 38.39M | 79.01M |
Cash Flow | |||||
| Free Cash Flow | 194.24M | 219.64M | 186.57M | 53.73M | 67.60M |
| Operating Cash Flow | 336.25M | 306.11M | 252.30M | 105.16M | 114.79M |
| Investing Cash Flow | -301.42M | -132.74M | -136.59M | 6.58M | -48.62M |
| Financing Cash Flow | -53.53M | -45.81M | -112.12M | -43.17M | -62.39M |
Regis Healthcare Ltd. Technical Analysis
Negative
6.12
Price Trends
6.27
Negative
6.27
Negative
6.55
Negative
Market Momentum
>-0.01
Positive
44.72
Neutral
40.23
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:REG, the sentiment is Negative. The current price of 6.12 is below the 20-day moving average (MA) of 6.23, below the 50-day MA of 6.27, and below the 200-day MA of 6.55, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 44.72 is Neutral, neither overbought nor oversold. The STOCH value of 40.23 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:REG.
Regis Healthcare Ltd. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | AU$84.32M | 10.71 | 14.03% | ― | 28.40% | -22.71% | |
63 Neutral | AU$10.10B | 16.28 | 7.20% | 4.99% | 15.53% | 15.11% | |
61 Neutral | AU$10.19B | 42.14 | 5.75% | 2.06% | 8.65% | 3233.99% | |
57 Neutral | AU$308.62M | -0.75 | -114.08% | ― | 2.16% | 21.04% | |
53 Neutral | AU$1.84B | 33.48 | -162.99% | 2.76% | 16.55% | 13.42% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
46 Neutral | AU$8.56M | -9.23 | -1301.30% | ― | 67.74% | 78.79% |
* Healthcare Sector Average
AU:REG
Regis Healthcare Ltd.
6.11
-1.51
-19.78%
AU:EPN
Epsilon Healthcare Limited
0.02
0.00
0.00%
AU:HLS
Healius Limited
0.43
-0.49
-53.30%
AU:RHC
Ramsay Health Care
44.02
10.65
31.92%
AU:AHC
Austco Healthcare Limited
0.23
-0.12
-35.71%
AU:SHL
Sonic Healthcare Limited
20.06
-2.76
-12.11%
Regis Healthcare Ltd. Corporate Events
Regis Healthcare Sets 2026 AGM Date and Director Nomination Deadline
Aug 23, 2026
Regis Healthcare has scheduled its 2026 Annual General Meeting for Tuesday, 17 November, at 10:00am AEDT, with detailed participation instructions to be issued in the forthcoming Notice of Meeting. The company has also set 14 September 2026 as the...
Regis Healthcare Files Updated ASX Corporate Governance Statement
Aug 23, 2026
Regis Healthcare Limited has lodged its corporate governance statement for the year ended 30 June 2026 with the ASX, confirming that the document is current as of 21 August 2026 and available on its website. The statement outlines how the company ...
Regis Healthcare Delivers Strong FY26 Results and Expands Aged Care Portfolio
Aug 23, 2026
Regis Healthcare reported a strong FY26, with revenue from services rising 16% to $1.35 billion and underlying EBITDA up 10% to $138 million, while statutory profit increased 14% to $55.7 million. Net operating cash flow climbed to $336.3 million,...
Regis Healthcare appoints new CFO to drive next growth phase
Aug 23, 2026
Regis Healthcare has appointed experienced finance executive Stuart Hooper as its new Chief Financial Officer, effective 1 September 2026, succeeding outgoing CFO Rick Rostolis. Hooper brings extensive healthcare, infrastructure and corporate fina...
Regis Healthcare to acquire Royal Freemasons’ Victorian home care business
Aug 2, 2026
Regis Healthcare has entered a binding agreement to acquire Royal Freemasons Homes of Victoria’s home care business, adding around 480 clients and expanding its presence in Melbourne. The deal, funded from existing cash and subject to regula...
Regis Healthcare CFO Rick Rostolis to Retire After Guiding Growth and M&A Strategy
Jul 12, 2026
Regis Healthcare has announced the retirement of Chief Financial Officer Rick Rostolis, whose four-decade executive career included key ASX-listed CEO and CFO roles. Since joining Regis, Rostolis has strengthened the company’s financial posi...
Regis Healthcare Issues New Unquoted Performance Rights Under Staff Incentive Plan
Jun 25, 2026
Regis Healthcare Limited has issued 17,085 new performance rights under its employee incentive scheme, with these securities not intended to be quoted on the ASX. The unquoted performance rights, issued on June 25, 2026, form part of the company&#...
Regis Healthcare reports lapse of performance rights and updates capital structure
Jun 22, 2026
Regis Healthcare Limited has reported the cessation of 782,814 performance rights, which lapsed after certain conditions attached to these rights were not met or could no longer be satisfied. The lapse reduces the pool of potential future equity i...
Regis Healthcare Discloses Final Director Interest as Linda Mellors Exits Board
Jun 19, 2026
Regis Healthcare has announced that director Linda Jane Mellors ceased to be a director on 19 June 2026, triggering the lodgement of a final director’s interest notice with the ASX. The notice details Mellors’ holdings at cessation, in...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.